Non-Hodgkin's Lymphoma Reversal with Dichloroacetate | Zendy

D. F. Flavin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Non-Hodgkin's Lymphoma Reversal with Dichloroacetate

Author(s) -

D. F. Flavin

Publication year - 2010

Publication title -

journal of oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.228

H-Index - 54

eISSN - 1687-8469

pISSN - 1687-8450

DOI - 10.1155/2010/414726

Subject(s) - medicine , lymphoma , complete remission , chemotherapy , stage (stratigraphy) , lymph , follicular lymphoma , hodgkin lymphoma , surgery , oncology , radiology , pediatrics , pathology , paleontology , biology

In June 2007, a 48-year-old male patient, diagnosed with Stage 4 Non-Hodgkin's Follicular Lymphoma (NHL), was treated for 3 months with conventional chemotherapy resulting in a complete remission. Almost one year later tumors returned in the nasopharynx and neck lymph glands. Refusing all suggested chemotherapies, the patient began self-administering dichloroacetate (DCA) 900 mg daily with a PET scan showing complete remission four months later. Since his last PET scan, May, 2009, he remains tumor-free from continuous DCA usage.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research